Precision Surgery for Pediatric Hydrocephalus: VPS vs. ETV With ML-Guided Prediction
VPS ETV ML
Individualized Treatment Strategies and Long-term Prognosis of Congenital Hydrocephalus: An Integrated Analysis Based on Multicenter Data and Machine Learning
1 other identifier
observational
800
1 country
1
Brief Summary
Study type: Multicenter retrospective cohort study with prospective validation Primary purpose: To determine whether an individualized, imaging-guided treatment algorithm Ventriculoperitoneal shunt (VPS) vs endoscopic third ventriculostomy (ETV) improves 2-year neurodevelopmental outcomes in children \<18 y with congenital hydrocephalus. Main questions
- Does ETV produce higher 6-month surgical success and lower 2-year re-intervention rates than VPS in prespecified subgroups (age ≥3 y, obstructive hydrocephalus, normal basal cisterns)?
- Does a machine-learning model (ETV-PS) using pre-operative MRI features accurately predict ETV success (AUC ≥0.80) and thereby reduce unnecessary re-operations?
- Does early, frequent programmable-valve pressure adjustment after VPS decrease over-shunting headaches and improve 2-year cognitive scores compared with standard, infrequent adjustment? Comparison: ETV group vs. VPS group (1:1 propensity-matched); within VPS cohort, frequent (≥3 adjustments in first 6 mo) vs. infrequent (\<3) pressure-tuning arms. Participants will
- Provide pre-operative clinical data and MRI/CT imaging.
- Undergo either VPS or ETV as clinically indicated; 320 VPS recipients receive programmable valves with protocol-driven pressure logs.
- Return for standardized neurodevelopmental testing Children's Memory Scale (CMS), Wechsler Intelligence Scale for Children(WISC), Pediatric Quality of Life Inventory(PedsQL) and imaging at 6 mo, 1 y and 2 y; valve adjustments tracked electronically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2024
CompletedFirst Submitted
Initial submission to the registry
December 29, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedJanuary 12, 2026
May 1, 2024
8 years
December 29, 2025
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Surgical success rate at 6 months post-operation
defined as stable or reduced ventricular volume on MRI/CT without need for re-intervention.
6 months
Secondary Outcomes (2)
2-year re-intervention rate
2 years
Cognitive improvement
2 years
Study Arms (2)
ETV group
All undergo endoscopic third ventriculostomy as initial treatment
VPS group
* 320 receive a programmable valve with protocol-driven pressure adjustments * 80 receive a fixed-pressure valve (included only in VPS-vs-ETV comparisons, excluded from valve-management sub-analysis)
Interventions
Eligibility Criteria
800 children ≤17 years with congenital hydrocephalus recruited from 6 tertiary pediatric neurosurgical centers; 1:1 matched VPS (n=400) vs ETV (n=400) cohorts balanced for age, sex, and hydrocephalus subtype.
You may qualify if:
- Age 0-17.99 years at surgery
- Congenital hydrocephalus confirmed by clinical and MRI/CT findings
- First surgical treatment: either VPS or ETV
- Complete pre-operative MRI/CT and ≥ 2-year follow-up data available
You may not qualify if:
- Secondary hydrocephalus (tumor, infection, trauma)
- Severe comorbidities affecting neuro-developmental assessment (e.g., major congenital heart disease, genetic-metabolic disorders)
- Incomplete baseline imaging or follow-up \< 2 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 29, 2025
First Posted
January 9, 2026
Study Start
January 1, 2016
Primary Completion
December 30, 2023
Study Completion
January 20, 2024
Last Updated
January 12, 2026
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL